Secretary-General of the Liberia College of Physicians and Surgeons (LCPS) Dr. Stephen B. Kennedy
Liberia Might Host Two Ebola Vaccines Trials
By Calvin Brooks
MONROVIA, September 26 (LINA) -The Secretary-General of the Liberia College of Physicians and Surgeons (LCPS) has disclosed that there are two potential candidate vaccines that are being discussed for clinical trial that might be conducted in Liberia in the next few weeks or months.
Dr. Stephen B. Kennedy explained that one of these vaccines was developed by the U. S. National Institute of Health which is part of the United States Department of Health and Human Services in conjunction with a pharmaceutical company.
He said the second vaccine was developed by the Public Health Agency of Canada.
Dr. Kennedy made the disclosure Thursday at the Ministry of Information, Culture and Tourism Affairs (MICAT) regular Ebola press briefing on Capitol Hill.
He indicated that the two vaccines have shown promising results, and that the World Health Organization (WHO) is expected to hold a meeting in Geneva next week and that Liberia might be considered as one of the sites for testing the vaccines.
He pointed out that if the safety trial in Liberia is found to be effective, a huge portion of those vaccines will be provided to Liberia free of charge for people to be protected against the Ebola virus disease.